Program Leader:
Prof GOH Boon Cher
Deputy Director, CSI Singapore
Experimental Therapeutics Program
The experimental therapeutics (CSI ET) program aims to develop novel therapeutics and uncover optimal combinations of drugs for cancer treatment through better understanding of mechanisms of action and drug resistance. Ultimately, advances in cancer treatment will evolve from well construed clinical trial design that are better informed by laboratory and clinical drug development. The CSI ET program scientists have a close relationship with the clinician scientists and clinical trial team at the Hematology-Oncology Research Group (HORG) of NUHS, a highly experienced clinical trial group conducting phase I-III clinical trials.
